Amgen Inc (AMGN)
274.59
-1.79
(-0.65%)
USD |
NASDAQ |
Apr 30, 14:41
Amgen 1 Year Total Returns (Daily): 19.16% for April 29, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| April 29, 2024 | 19.16% |
| April 26, 2024 | 16.86% |
| April 25, 2024 | 13.71% |
| April 24, 2024 | 15.44% |
| April 23, 2024 | 15.95% |
| April 22, 2024 | 15.26% |
| April 19, 2024 | 12.90% |
| April 18, 2024 | 10.36% |
| April 17, 2024 | 10.03% |
| April 16, 2024 | 9.83% |
| April 15, 2024 | 9.78% |
| April 12, 2024 | 10.73% |
| April 11, 2024 | 11.00% |
| April 10, 2024 | 9.77% |
| April 09, 2024 | 10.32% |
| April 08, 2024 | 9.85% |
| April 05, 2024 | 10.13% |
| April 04, 2024 | 11.95% |
| April 03, 2024 | 16.04% |
| April 02, 2024 | 18.10% |
| April 01, 2024 | 21.02% |
| March 28, 2024 | 23.23% |
| March 27, 2024 | 24.99% |
| March 26, 2024 | 22.36% |
| March 25, 2024 | 21.95% |
| Date | Value |
|---|---|
| March 22, 2024 | 24.21% |
| March 21, 2024 | 22.89% |
| March 20, 2024 | 20.25% |
| March 19, 2024 | 22.23% |
| March 18, 2024 | 21.86% |
| March 15, 2024 | 18.31% |
| March 14, 2024 | 21.73% |
| March 13, 2024 | 22.34% |
| March 12, 2024 | 25.44% |
| March 11, 2024 | 24.91% |
| March 08, 2024 | 23.87% |
| March 07, 2024 | 23.31% |
| March 06, 2024 | 21.60% |
| March 05, 2024 | 21.78% |
| March 04, 2024 | 22.99% |
| March 01, 2024 | 22.68% |
| February 29, 2024 | 22.18% |
| February 28, 2024 | 23.80% |
| February 27, 2024 | 22.78% |
| February 26, 2024 | 26.68% |
| February 23, 2024 | 25.79% |
| February 22, 2024 | 24.82% |
| February 21, 2024 | 22.99% |
| February 20, 2024 | 21.84% |
| February 16, 2024 | 25.20% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-16.48%
Minimum
Oct 07 2021
50.38%
Maximum
Jul 20 2020
10.65%
Average
8.10%
Median
Sep 04 2019
1 Year Total Returns (Daily) Benchmarks
| Gilead Sciences Inc | -16.63% |
| Johnson & Johnson | -7.56% |
| Eli Lilly and Co | 87.77% |
| Merck & Co Inc | 15.78% |
| Vertex Pharmaceuticals Inc | 16.28% |